Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone versus ketorolac injection for De Quervain's tenosynovitis in adults with type 2 diabetes
IRCT20220611055139N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in de Quervain's tenosynovitis comparing Betamethasone injection with Ketorolac injection (2 arms). Primary endpoint: Pain control effectiveness. Started Aug 2022; status: completed.
02
Drugs
betamethasoneketorolac
03
Conditions
de Quervain's tenosynovitis
Beyond the preview
Go deeper on IRCT20220611055139N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220611055139N1.